Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B van Kessel
The Therapeutic Human CD38 Antibody Daratumumab Improves the Anti-Myeloma Effect of Newly Emerging Multi-Drug Therapies
Blood Cancer Journal
Oncology
Hematology
Related publications
Daratumumab Induces CD38 Internalization and Impairs Myeloma Cell Adhesion
OncoImmunology
Oncology
Allergy
Immunology
The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Daratumumab in Untreated Newly Diagnosed Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
Mechanism of Action of a New Anti-Cd38 Antibody: Enhancing Myeloma Immunotherapy
Clinical Cancer Research
Cancer Research
Oncology
Daratumumab-Mediated Lysis of Primary Multiple Myeloma Cells Is Enhanced in Combination With the Human Anti-Kir Antibody IPH2102 and Lenalidomide
Haematologica
Hematology
Phase I Study of the Anti-FcRH5 Antibody-Drug Conjugate DFRF4539A in Relapsed or Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Novel Therapies in Multiple Myeloma for Newly Diagnosed Nontransplant Candidates
Cancer Journal
Cancer Research
Oncology
CD38: From Positive to Negative Expression After Daratumumab Treatment
Cureus
Structural Characterization of a Potent Humanized Anti-Cd38 Antibody in Phase I
Acta Crystallographica Section A: Foundations and Advances
Materials Science
Condensed Matter Physics
Theoretical Chemistry
Biochemistry
Structural Biology
Inorganic Chemistry
Physical